These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10516368)

  • 61. [Stability of hemoglobin levels: an indispensible paradigm change in medical management].
    Zaoui P; Deray G; Ortiz JP; Rostaing L
    Nephrol Ther; 2011 Feb; 7(1 Suppl 2):H5-7. PubMed ID: 21371678
    [No Abstract]   [Full Text] [Related]  

  • 62. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?
    Sav T; Tokgoz B; Sipahioglu MH; Deveci M; Sari I; Oymak O; Utas C
    Ren Fail; 2007; 29(4):423-6. PubMed ID: 17497463
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.
    Plummer ES; Crary SE; McCavit TL; Buchanan GR
    Pediatr Blood Cancer; 2013 Nov; 60(11):1747-52. PubMed ID: 23832487
    [TBL] [Abstract][Full Text] [Related]  

  • 64. IV iron use in patients with higher serum ferritin: case study on anemia in kidney disease.
    Larson K
    Nephrol Nurs J; 2008; 35(2):184-93; quiz 194-5. PubMed ID: 18472686
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [A single infusion of iron dextran in iron deficiency and iron-deficiency anemia].
    Krause U
    Nord Med; 1968 Aug; 80(35):1140-3. PubMed ID: 4881092
    [No Abstract]   [Full Text] [Related]  

  • 66. Goodbye oral iron therapy?
    Forman E
    Pediatr Blood Cancer; 2013 Nov; 60(11):1731. PubMed ID: 23900795
    [No Abstract]   [Full Text] [Related]  

  • 67. Iron deficiency in non-dialysis chronic kidney disease.
    Fishbane S; Singh AK
    Kidney Int; 2009 Apr; 75(7):752-4. PubMed ID: 18563050
    [No Abstract]   [Full Text] [Related]  

  • 68. [Factors influencing responsiveness to treatment in children with renal anemia in end stage renal disease].
    Haliţchi CI; Munteanu M; Brumariu O
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):94-9. PubMed ID: 18677909
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative response to single or divided doses of parenteral iron for functional iron deficiency in hemodialysis patients receiving erythropoietin (EPO).
    Saltissi D; Sauvage D; Westhuyzen J
    Clin Nephrol; 1998 Jan; 49(1):45-8. PubMed ID: 9491286
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anemia management in chronic kidney disease: intravenous iron steps forward.
    Coyne DW; Auerbach M
    Am J Hematol; 2010 May; 85(5):311-2. PubMed ID: 20232350
    [No Abstract]   [Full Text] [Related]  

  • 71. Iron dextran treatment in peritoneal dialysis patients on erythropoietin.
    Suh H; Wadhwa NK
    Adv Perit Dial; 1992; 8():464-6. PubMed ID: 1361849
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transdermal iron replenishment therapy.
    Modepalli N; Shivakumar HN; Kanni KL; Murthy SN
    Ther Deliv; 2015; 6(6):661-8. PubMed ID: 26149783
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical perspective: iron replacement therapy in chronic heart failure.
    Cowie MR; Lucas R
    Int J Clin Pract; 2011 Jun; 65(6):645-8. PubMed ID: 21564435
    [No Abstract]   [Full Text] [Related]  

  • 74. Lessons from NKF-DOQI: iron management.
    Van Wyck DB
    Semin Nephrol; 2000 Jul; 20(4):330-4. PubMed ID: 10928334
    [No Abstract]   [Full Text] [Related]  

  • 75. Anemia and iron management.
    Besarab A
    Semin Dial; 2011; 24(5):498-503. PubMed ID: 21906169
    [No Abstract]   [Full Text] [Related]  

  • 76. Refractory anemia in a patient with allergy to intravenous iron drugs.
    Fishbane S
    Kidney Int; 2006 May; 69(10):1910-3. PubMed ID: 16625145
    [No Abstract]   [Full Text] [Related]  

  • 77. Intravenous iron in pediatric patients.
    Greenbaum LA; Nelson T
    Am J Kidney Dis; 1998 May; 31(5):897-8. PubMed ID: 9590207
    [No Abstract]   [Full Text] [Related]  

  • 78. Second Generation Parenteral Iron Transforming Anemia Management.
    Hoffman ML
    Nephrol Nurs J; 2021; 48(2):181-182. PubMed ID: 33886249
    [No Abstract]   [Full Text] [Related]  

  • 79. Transfusion medicine illustrated. Pseudohemolysis with iron dextran therapy.
    Brecher ME; Hay SN
    Transfusion; 2002 Feb; 42(2):135. PubMed ID: 11896324
    [No Abstract]   [Full Text] [Related]  

  • 80. [Iron supplementation in anemia treatment].
    Abensur H; Castro MC
    J Bras Nefrol; 2014 Mar; 36(1 Suppl 1):15-8. PubMed ID: 24770598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.